The Bell Potter report has also estimated fully franked div commencing in 2019.
Year end June 30 2016 2017 2018e 2019e 2020e
Sales revenue ($m) 30.1 35.4 42.3 49.9 58.2
EBITDA (A$m) 3.8 5.8 10.7 15.6 21
NPAT (reported) (A$m) 0.8 0.7 7.5 11.3 15.3
NPAT (cash) (A$m) 2.5 3.8 8.1 11.8 15.9
EPS (cash) (cps) 0.6 1.0 2.0 3.0 4.0
EPS growth (%) 49% 111% 47% 34%
EV/EBITDA (x) 40.7 26.4 14.4 9.8 7.3
Dividend (¢ps) 0.0 0.0 0.0 1.9 2.5
Yield (%) 0.0% 0.0% 0.0% 4.6% 6%
ROE (%) 12.4% 19.8% 34.5% 37.8% 42%
Franking (%) 0.0% 100.0% 100.0% 100.0% 100%
Cash (ZERO DEBT) 10.4 9.0 16.6 24.4 31.0
Half end December 31- 1H18e 1H19e 1H20e
Interim DPS (cents) 0.9 1.2 1.6
OLI..
- Forums
- ASX - By Stock
- News: PPS Praemium says FY net profit attributable to members $46,967, up 132.5 pct
The Bell Potter report has also estimated fully franked div...
Featured News
Add PPS (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.0¢ |
Change
-0.005(0.75%) |
Mkt cap ! $250.6M |
Open | High | Low | Value | Volume |
66.0¢ | 66.8¢ | 66.0¢ | $461.3K | 695.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4475 | 66.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 139465 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 0.590 |
1 | 52000 | 0.575 |
6 | 111190 | 0.570 |
2 | 35080 | 0.565 |
5 | 50580 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 131318 | 9 |
0.605 | 48960 | 3 |
0.610 | 44045 | 4 |
0.615 | 78993 | 6 |
0.620 | 110891 | 5 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
PPS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online